Final recommendations on lung cancer screening

December 30, 2013

Final word: Task Force says screen high-risk populations for lung cancer

High-risk adults between the ages of 55 and 80 should receive annual lung cancer screening with low-dose computed tomography, according to final recommendations from the U.S. Preventive Services Task Force being published in Annals of Internal Medicine. Heavy smokers or former heavy smokers who have quit within the past 15 years are considered high risk. Smoking is responsible for about 85 percent of lung cancers in the United States. The risk for developing lung cancer also increases with age, with most lung cancers occurring in people age 55 or older. The recommendation is based on comprehensive review of the evidence and the results of modeling studies predicting the benefits and harms of screening programs based on different screening intervals, age ranges, smoking histories, and time since quitting. The full recommendation is free to the public and can be viewed at http://www.annals.org/article.aspx?doi=10.7326/M13-2771. The comparative modeling study can be viewed at http://www.annals.org/article.aspx?doi=10.7326/M13-2316.

Two commentaries accompany the Task Force recommendations. In the first, the author commends the comprehensive and unbiased evidence reviews that underlie Task Force recommendations but expresses concern about the Task Force's reliance on modeling data to fill evidence gaps, especially with regard to the lung cancer screening recommendations. The authors of a second editorial describe some of the practical issues associated with putting the Task Force recommendations into practice. Of most concern, how patient selection actually occurs is not addressed in the guidelines. Patients who are interested or should consider CT screening for lung cancer will need to be counseled and referred. The authors wonder if primary care providers have the tools necessary to do this and if the health care system will be willing to support it.
-end-


American College of Physicians

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.